Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Many Young Adults Misusing Medical Marijuana, Study SuggestsAnother Possible Effect of Climate Change: More Preemie Babies1 in 18 U.S. Teens Carries a Gun to School: StudyU.S. Poison Centers Field More Calls About Psychoactive Substances: StudyDoctors' Group Calls for Ban on Most Vaping ProductsAs Disease Outbreaks Tied to 'Anti-Vaxxers' Rise, States Take ActionAHA News: Millions Who Never Smoked Cigarettes Are Using Other Tobacco ProductsMost Docs Don't Know Hair Care Is a Barrier to Exercise for Black WomenHealth Tip: Do's and Don'ts for Calling 911Climate Change Will Hurt Kids Most, Report WarnsYou Won't Get Sued If You Do CPR, Review SuggestsRacial Bias Seen in Heart TransplantsTrump Administration Wants to Raise Age to Buy E-Cigs to 21Juul Stops Sales of Mint-Flavored E-CigarettesDo You Take Biotin Supplements? They Could Affect Your Medical TestsClimate Change a 'Threat to Human Well-Being,' Scientists SayAnti-Vaxxers Find Ways Around States' 'Personal Exemption' BansMedia Reports on Celeb Suicides Could Trigger CopycatsStill Way Too Much Smoking in Movies Aimed at KidsConsumers' Orders Changed Slightly After Calorie Counts Added to MenusReport Finds Americans' Health Is FlaggingAfter Mass Shootings, Docs Even Less Likely to Mention Gun SafetyBan on Sale of Sugary Drinks Trimmed Employees' WaistlinesAre You Accessing All Your Medical Records Online?Independent Pharmacies Are Closing Down Across the U.S.Language Barriers May Mean Repeat Visits to the HospitalInterest in CBD Products Keeps Soaring, but Health Experts WaryJuul Halts Sale of Fruit, Dessert Flavors of E-CigarettesShrinking Youth Group Aids Global Decline in HomicidesWhen Meds Are Free, Patients Take Them More OftenSpurred by Mass Shootings, More Americans View Mentally Ill as ViolentPacemakers, Insulin Pumps Could Be Hacking Targets: FDAAHA News: Make Neighborhoods Green for Heart Health? The Idea Is Taking RootPoll Finds Many Young Americans Think Vaping is SafeWhat Do Hospital Cyber Attackers Want to Know About You?U.S. Minorities' Recent Health Gains May Be SlowingPaid Family Leave Helps Keep Babies' Vaccines on Track: StudyDon't Let Fear of Cancer Keep You From Doctor VisitsMaker Halts Distribution of Generic Zantac Due to Possible CarcinogenCould Profit Be a Factor in Kidney Transplant Decisions?Get Up-to-the-Minute Safety Alerts Sent Straight to Your InboxPurdue Pharma to Settle Opioid Crisis Lawsuits, May Pay Up to $12 BillionWould a Health Warning on Every Cigarette Help Smokers Quit?Docs Prescribe More Opioids at Certain Time of DayFDA Warns Juul About Illegal Marketing Claims and Pitch to YouthComing Soon: A 'Pot Breathalyzer'?More CT, MRI Scans Being Used, Despite Calls to Cut BackCancer Overtakes Heart Disease as #1 Killer of Middle-Aged in Wealthy NationsOxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid ClaimsThousands of Kidneys Thrown Away by U.S. Transplant Centers
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Purdue Pharma to Settle Opioid Crisis Lawsuits, May Pay Up to $12 Billion

HealthDay News
by By Dennis ThompsonHealthDay Reporter
Updated: Sep 11th 2019

new article illustration

WEDNESDAY, Sept. 11, 2019 (HealthDay News) -- OxyContin maker Purdue Pharma has reached a tentative settlement with a coalition of states and local governments that sued the company over its role in America's ongoing opioid crisis, press reports say.

The settlement requires the dissolution of Purdue Pharma and the formation of a new company that would continue to sell OxyContin, the firm's blockbuster opioid, the New York Times reported.

Proceeds from the new company would be used to pay the plaintiffs in the lawsuit and combat the opioid epidemic. Purdue also would donate drugs under development for addiction treatment and overdose reversal.

The family that holds a controlling interest in Purdue Pharma, the Sacklers, would be required to relinquish their hold on the company, the Washington Post said.

The deal is said to be worth between $10 billion to $12 billion, including a $3 billion payment from the Sacklers over seven years, the Times and the Post reported.

The settlement would not contain any statement of wrongdoing.

The executive committee of 22 states and more than 2,000 cities and counties taking part in the federal lawsuit is recommending that the deal be accepted, the Times said.

However, some state attorneys general remain opposed to a deal, objecting that the Sacklers are not forking over enough cash from their personal fortunes, according to news reports.

"I cannot speak to other states or divulge confidential negotiations, but Connecticut has not agreed to any settlement," Connecticut Attorney General William Tong said in a statement. "The scope and scale of the pain, death and destruction that Purdue and the Sacklers have caused far exceeds anything that has been offered thus far."

The settlement comes about six weeks before the start of the first federal trial related to the opioid epidemic lawsuits.

The trial is slated to take place before a federal judge in Cleveland who has issued tough pretrial rulings against Purdue and the Sacklers, the Times noted, darkening the company's prospects in court.

Meanwhile, more than 40 individual lawsuits against drug companies are making their way through state courts, as well as some lawsuits targeting the Sacklers personally, the Post reported.

More than 200,000 people have died from prescription opioid overdoses since 1999, according to federal statistics. Another 200,000 have died due to overdoses from illicit opioids such as heroin and fentanyl.

More information

The U.S. Centers for Disease Control and Prevention have more about the opioid epidemic.




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net